Hu GY - Search Results

1

Mefunidone ameliorates lipopolysaccharide-induced acute lung injury through inhibiting MAPK signaling pathway and enhancing Nrf2 pathway.

Yao TT, Zhang Y, He RL, Lv X, He YJ, Li MY, Han YY, Long LZ, Jiang GL, Cheng XY, Hu GY, Li QB, Tao LJ, Meng J. Yao TT, et al. Among authors: hu gy. Int Immunopharmacol. 2022 Dec;113(Pt A):109263. doi: 10.1016/j.intimp.2022.109263. Epub 2022 Nov 2. Int Immunopharmacol. 2022. PMID: 36334370 Free article.

2

[Effects of 1-(3-fluorophenyl)-5-methyl-2-(1H)-pyridone on renal fibroblast in rats].

Tao LJ, Zhang J, Hu GY. Tao LJ, et al. Among authors: hu gy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Apr;29(2):139-41. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004. PMID: 16145895 Chinese.

3

Fluorofenidone attenuates collagen I and transforming growth factor-beta1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells.

Peng ZZ, Hu GY, Shen H, Wang L, Ning WB, Xie YY, Wang NS, Li BX, Tang YT, Tao LJ. Peng ZZ, et al. Among authors: hu gy. Nephrology (Carlton). 2009 Sep;14(6):565-72. doi: 10.1111/j.1440-1797.2009.01129.x. Nephrology (Carlton). 2009. PMID: 19712256

4

Fluorofenidone inhibits TGF-beta1 induced CTGF via MAPK pathways in mouse mesangial cells.

Wang L, Hu GY, Shen H, Peng ZZ, Ning WB, Tao LJ. Wang L, et al. Among authors: hu gy. Pharmazie. 2009 Oct;64(10):680-4. Pharmazie. 2009. PMID: 19947172

5

Fluorofenidone protects mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-1beta release.

Tang Y, Li B, Wang N, Xie Y, Wang L, Yuan Q, Zhang F, Qin J, Peng Z, Ning W, Wang L, Hu G, Li J, Tao L. Tang Y, et al. Int Immunopharmacol. 2010 May;10(5):580-3. doi: 10.1016/j.intimp.2010.02.005. Epub 2010 Feb 13. Int Immunopharmacol. 2010. PMID: 20159052

6

Fluorofenidone inhibits Ang II-induced apoptosis of renal tubular cells through blockage of the Fas/FasL pathway.

Ning WB, Hu GY, Peng ZZ, Wang L, Wang W, Chen JY, Zheng X, Li J, Tao LJ. Ning WB, et al. Among authors: hu gy. Int Immunopharmacol. 2011 Sep;11(9):1327-32. doi: 10.1016/j.intimp.2011.04.016. Epub 2011 May 14. Int Immunopharmacol. 2011. PMID: 21586345

7

Fluorofenidone attenuates renal interstitial fibrosis in the rat model of obstructive nephropathy.

Li BX, Tang YT, Wang W, Xie YY, Wang NS, Yuan QJ, Zhang FF, Peng ZZ, Hu GY, Tao LJ. Li BX, et al. Among authors: hu gy. Mol Cell Biochem. 2011 Aug;354(1-2):263-73. doi: 10.1007/s11010-011-0826-1. Epub 2011 May 19. Mol Cell Biochem. 2011. PMID: 21594754

8

Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.

Yuan Q, Wang R, Peng Y, Fu X, Wang W, Wang L, Zhang F, Peng Z, Ning W, Hu G, Wang Z, Tao L. Yuan Q, et al. Am J Nephrol. 2011;34(2):181-94. doi: 10.1159/000329080. Epub 2011 Jul 23. Am J Nephrol. 2011. PMID: 21791914

9

Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.

Li Q, Fang H, Wang X, Hu G, Wang Q, Xu W. Li Q, et al. Bioorg Med Chem Lett. 2012 Jan 15;22(2):850-3. doi: 10.1016/j.bmcl.2011.12.048. Epub 2011 Dec 16. Bioorg Med Chem Lett. 2012. PMID: 22206607

10

Synthesis, pharmacokinetics, and pharmacodynamics studies of valsartan peptide derivatives.

Wu C, Hu Y, Li Q, He L, Chen J, Cheng Z, Li Y, Hu G. Wu C, et al. Arch Pharm (Weinheim). 2012 May;345(5):393-400. doi: 10.1002/ardp.201100377. Epub 2012 Jan 20. Arch Pharm (Weinheim). 2012. PMID: 22266917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters